Form 10-Q · Quarterly report
Nordson Corporation 10-Q, filed Aug 20, 2026
- Filed
- CIK
- 0000072331
- Accession no.
- 0000072331-26-000054
Summary
Nordson Corporation reported third-quarter fiscal 2026 sales of $817.7 million, up 10.3% from a year earlier, and net income of $152.8 million, up 21.5%, with organic sales growth across its three segments led by a 30.9% increase in Advanced Technology Solutions. For the nine months ended July 31, 2026, sales rose 9.2% to $2.23 billion and net income rose 21.2% to $403.5 million.
Key points
- Third-quarter gross margin was 55.5%, up from 54.8% a year earlier.
- Advanced Technology Solutions organic sales rose 30.9% in the quarter, driven by electronics dispense and test and inspection product lines.
- Nine-month sales were $2.228 billion, up 9.2%, and net income was $403.5 million, up 21.2%.
- During the second quarter of 2026, Nordson completed a partial settlement of its U.S. pension plan, using $104.1 million of plan assets to purchase a group annuity contract.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as: catheters, cannulas, medical balloons and medical tubing. These products are supported with extensive application expertise and direct global sales and service. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.